Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
NAGE
$3.02
-0.98%
NAGE · Niagen Bioscience, Inc.
$3.02
-0.03 (-0.98%)
At close · Aug 14
Market Cap
$242.13M
Shares
79.13M
All earnings calls
Earnings call · FY2024 Q2
Niagen Bioscience, Inc. Q2 FY2024 Earnings Call
Niagen Bioscience, Inc. Q2 FY2024 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$22.74M
+11.9% YoY
Diluted EPS
$0.00
Gross margin
60.2%
-0.6 pp YoY
Net income
-$15,000
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 7, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 7, 2024 · complete as-filed document